In reply to: Letter by Derimay et al. regarding the article, 'A randomized trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial' by Rampat et al.

摘要

We would like to thank Derimay et al. for their interest in our study [1 ].In line with EBC recommendation, we agree that a distal sizing strategy is preferable when using metal stents to treat coronary bifurcation disease [2]. Such a strategy avoids distal oversizing while allowing correction of proximal malapposition with liberal Proximal Optimisation Technique without incurring a significant risk of damage to the stent. However caution must be exercised with the ABSORB BVS due to the inherent limits of its expansion capacity. In fact, this difference in mechanical properties between stent and scaffold was the main impetus behind